e-learning
resources
London 2016
Sunday, 04.09.2016
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled treatment of COPD: A delphi consensus statement
Vincent Ninane (Bruxelles, Belgium), Vincent Ninane, Jean-Louis Corhay, Paul Germonpré, Wim Janssens, Guy Joos, Giuseppe Liistro, Walter Vincken, An Lehouck
Source:
International Congress 2016 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
Poster Discussion
Number:
306
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vincent Ninane (Bruxelles, Belgium), Vincent Ninane, Jean-Louis Corhay, Paul Germonpré, Wim Janssens, Guy Joos, Giuseppe Liistro, Walter Vincken, An Lehouck. Inhaled treatment of COPD: A delphi consensus statement. Eur Respir J 2016; 48: Suppl. 60, 306
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Importance of inhalation device in asthma and COPD: A consensus using Delphi
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD?
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Effects of ciclesonide on the management of stable COPD with airway eosinophilia
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Preference, satisfaction and critical errors with Genuair
®
and Breezhaler
®
in patients with COPD
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Inhalation technique education and its impact in asthma and COPD
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Educational inhaler technique interventions in asthma & COPD patients: A systematic review
Source: International Congress 2016 – Management of asthma and COPD in primary care
Year: 2016
Reproducibility of inhaler use and pulmonary drug deposition in COPD
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept